Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases. [electronic resource] by
- Martini, Paolo G V
- Cook, Lynette C
- Alderucci, Scott
- Norton, Angela W
- Lundberg, Dianna M
- Fish, Susan M
- Langsetmo, Knut
- Jönsson, Göran
- Lood, Christian
- Gullstrand, Birgitta
- Zaleski, Kate J
- Savioli, Nancy
- Lottherand, Jason
- Bedard, Charles
- Gill, John
- Concino, Michael F
- Heartlein, Michael W
- Truedsson, Lennart
- Powell, Jan L
- Tzianabos, Arthur O
Producer: 20110315
In:
BMC immunology vol. 11
Availability: No items available.
|